Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21161 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2023-08-26 (nasdaq.com)
TIBAX - Thornburg Investment Income Builder Fund - Discloses $184.08K Position in Novartis (SIX:NOVN)
Fintel reports that TIBAX - Thornburg Investment Income Builder Fund - has filed a NP with the SEC disclosing ownership of 1,830.71K shares of Novartis AG (SIX:NOVN) valued at $184.08K.
Read more
2023-08-26 (nasdaq.com)
TIBAX - Thornburg Investment Income Builder Fund - Discloses $184.08K Position in Novartis (SIX:NOVN)
Fintel reports that TIBAX - Thornburg Investment Income Builder Fund - has filed a NP with the SEC disclosing ownership of 1,830.71K shares of Novartis AG (SIX:NOVN) valued at $184.08K.
Read more
2019-07-18 (fiercebiotech.com)
J&J, Novartis help Medicxi raise €400M biopharma fund
Medicxi has raised a €400 million ($448 million) biopharma investment fund. | Medicxi has raised a €400 million ($448 million) biopharma investment fund. Johnson & Johnson and Novartis pumped money into the fund as cornerstone strategic investors, helping Medicxi wrap up fundraising in record time.
Read more
2019-07-18 (fiercebiotech.com)
J&J, Novartis help Medicxi raise €400M biopharma fund
Medicxi has raised a €400 million ($448 million) biopharma investment fund. | Medicxi has raised a €400 million ($448 million) biopharma investment fund. Johnson & Johnson and Novartis pumped money into the fund as cornerstone strategic investors, helping Medicxi wrap up fundraising in record time.
Read more